When Sergeant First Class David Miller, a retired Army medic with 22 years of service, looked at the pharmacy bill for his diabetes medication, the nearly $150 co-pay for a 30-day supply felt like a punch to the gut. He gets his care through the Department of Veterans Affairs (VA), a system that’s supposed to honor his service, but the constant climb of VA drug costs was becoming a burden he couldn’t sustain. David’s story isn’t an outlier. His situation is a reality for millions of veterans, and it throws the problem of pharmaceutical spending into sharp relief, showing why we desperately need effective policy negotiation.
Key Takeaways
- Thanks to federal law (specifically 38 U.S.C. § 8126), the VA has special purchasing power that allows it to negotiate drug prices far below what other government agencies pay.
- New laws like the Inflation Reduction Act of 2022 are giving Medicare more power to negotiate drug prices, which could create a ripple effect that changes the VA’s own strategies.
- To cut down on what they pay, veterans can use the VA’s formulary system and get help from patient assistance programs to find cheaper medication options.
- Pushing for stronger drug cost negotiation policies is a direct way to make sure veterans can get the medicine they need without going broke.
The Weight of Medical Bills: David’s Dilemma
David is one of many veterans who depend on the VA for healthcare. His body carries the physical toll of multiple deployments and years in tough environments. After getting diagnosed with Type 2 diabetes a few years post-retirement, his daily life came to include a regimen of oral medications and insulin shots. He’s grateful for the quality of care he gets from his doctors at the Atlanta VA Medical Center, but the cost of his prescriptions is a constant source of anxiety. “It’s a constant tightrope walk,” David said in a recent interview, “between paying for groceries and making sure I have my meds. I served my country, and I feel like I’m still fighting a battle, but this one’s against the pharmacy counter.”
The VA doesn’t buy drugs like any other government agency. Where others often pay market rates or get standard commercial discounts, the VA has its own legal playbook. A law called the Veterans Health Care Act of 1992, particularly section 38 U.S.C. § 8126, forces drug companies to sell medications to the VA at a steep discount, often called the Federal Supply Schedule (FSS) price. That’s how the VA locks in some of the lowest drug prices in the country. Still, even with these discounts, the massive number of prescriptions and the staggering price of new specialty drugs puts financial pressure on the whole VA system and on individual vets like David.
Working through the Labyrinth: VA’s Negotiation Power and Its Limits
The VA’s power to negotiate drug prices is a huge advantage, but it’s a complicated system to work through. The department has its own national formulary, which is just a list of approved medications. Getting a drug that isn’t on that list means getting special approval, a process that can take a long time and frustrate everyone involved. The formulary itself is a negotiating tactic. By picking certain drugs for the list, the VA makes manufacturers compete on price to get their products included. “The formulary is designed to balance clinical effectiveness with cost-efficiency,” explained Dr. Evelyn Reed, a healthcare economist at Emory University who specializes in federal health programs. “It’s a balancing act between giving veterans the best care and keeping a lid on a budget that runs into the billions.”
Veteran homeowners. Want to lower your monthly payments?
See if a VA Cash Out Loan or VA Home Loan can put cash in your pocket or help you buy with $0 down. A specialist will review your options, free.
- VA Cash Out Loan: use up to 100% of your home’s equity
- VA Home Loan: buy a home with $0 down payment
- No cost, no obligation eligibility check
You’re all set.
A VA loan specialist will reach out shortly to review your Home Loan and Cash Out options.
This system gets constantly tested by the flood of new, expensive drugs, especially for chronic conditions. These new treatments hit the market with sky-high prices, and while the VA’s legal discounts help, they don’t erase the entire cost. For David, his first diabetes drug was cheap, but his condition got worse. When he needed a newer, more advanced insulin, his co-pays shot up. He remembers his VA pharmacist at the Decatur clinic sitting down with him to explain the tiered co-pay system and pointing him toward a VA patient assistance program. That program, thankfully, helped. Without that pharmacist’s advice, he admits he might have started rationing his insulin, a dangerous game for a diabetic.
The Broader Policy Field: Influences on VA Drug Costs
This drug cost fight isn’t just happening at the VA. Big changes in law, like the Inflation Reduction Act of 2022, have finally given Medicare the ability to negotiate prices on some high-cost drugs. Medicare’s negotiating power works differently from the VA’s, but what happens there will almost certainly have a ripple effect. “Any move towards greater drug price negotiation at the federal level sets a precedent,” Dr. Reed pointed out. It could give the VA a stronger position in future talks or just create a more competitive market among drug makers. The Centers for Medicare & Medicaid Services (CMS) is already moving forward, with the first negotiated prices set to go into effect in 2026. This move upends decades of pharmaceutical industry resistance to letting the government negotiate prices directly.
The pharmaceutical industry’s response, predictably, is that controlling prices kills innovation. It’s an argument they always make, but it conveniently ignores the massive public investment that goes into drug research and the eye-watering profits companies make. From my own time in health policy, I know a balanced approach is possible. We absolutely can encourage new drug development and still make sure life-saving meds are affordable, especially for the people who’ve served our country. It requires smart policy design.
What Veterans Can Do: Working through Costs and Advocating for Change
So what can a vet like David actually do? First, he has to get smart about the VA’s system and learn to advocate for himself. The VA has a few ways to manage drug costs. The most important step is to talk about costs with your VA doctor or pharmacist. A lot of the time, a generic version will work just as well and can slash your out-of-pocket expenses. Second, vets need to ask about the VA’s patient assistance programs, which can offer financial help or even free medicine if you qualify based on your income or other factors.
And on a bigger scale, veterans themselves can be a powerful force for change. Groups like the Veterans of Foreign Wars (VFW) and the American Legion are constantly on Capitol Hill fighting for veterans’ healthcare, including affordable medicine. When you add your voice to theirs, it sends a clear message. David has started going to his local VFW meetings, telling his story and getting others to get loud. “We fought for our country,” he says, with a new determination, “now we need to fight for our health.”
The fight against high drug prices isn’t over, but the VA’s negotiating muscle, combined with new federal policies, offers some real hope. By learning the system, using the resources out there, and speaking up, veterans can make sure their service is honored with the healthcare they were promised.
Conclusion
For any veteran trying to manage healthcare costs in the VA, the path forward involves getting proactive with providers and learning the system to lessen the hit from prescription drug prices.
How does the VA negotiate drug prices differently from Medicare?
The VA’s power comes from a long-standing law, 38 U.S.C. § 8126, that forces drug makers to give it a big discount, known as the Federal Supply Schedule (FSS) price. Medicare, on the other hand, is just getting started, having only recently gained limited negotiating power for some drugs through the Inflation Reduction Act of 2022. Those new Medicare prices won’t even kick in until 2026.
What is the VA formulary, and how does it affect medication costs?
The VA formulary is simply a list of drugs the VA prefers to prescribe because it has negotiated better prices for them. Getting a drug that isn’t on the list can be a hassle. Non-formulary medications often require special authorization and can come with higher co-pays if they’re approved for you.
Are there programs available to help veterans with high prescription co-pays?
Yes. The VA has patient assistance programs and other financial aid options to help veterans who are struggling with co-pays. The best way to get access is to talk about your financial situation with your VA healthcare provider or a VA benefits counselor. They know the system and can walk you through the applications.
How can veterans advocate for better drug cost policies?
You can get involved by calling your elected officials and joining veteran service organizations like the VFW or the American Legion. Sharing your own story is also incredibly effective. When enough vets speak up, it puts real pressure on policymakers to pass and enforce laws that guarantee affordable prescription drugs.
Will Medicare’s new drug negotiation policies impact VA drug prices?
While the policies are separate, the pressure Medicare is putting on drug companies could create a more competitive market overall. A manufacturer facing price negotiations from Medicare might be more willing to give the VA a better deal in the future. At a minimum, it sets a strong precedent for the federal government getting more aggressive on drug pricing.
“As Helen Miller, director of the Institute for Fiscal Studies (IFS), puts it, external: "We have a relatively new government with seemingly big ambitions but facing a long list of constraints.”
